Method Validation for Anticomplementary Activity of Human Immunoglobulin Drugs

M. A. Krivykh; O. G. Kornilova; N. D. Bunyatyan; E. V. Paramonova; R. A. Volkova; O. V. Fadeikina

doi:10.1007/s11094-016-1503-1

Method Validation for Anticomplementary Activity of Human Immunoglobulin Drugs

Авторы: Krivykh M.¹, Kornilova O.¹, Bunyatyan N.¹, Paramonova E.¹, Volkova R.¹, Fadeikina O.¹
Учреждения:
1. State Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
Выпуск: Том 50, № 9 (2016)
Страницы: 625-629
Раздел: Article
URL: https://journals.rcsi.science/0091-150X/article/view/244450
DOI: https://doi.org/10.1007/s11094-016-1503-1
ID: 244450

Цитировать

Полный текст

Открытый доступ
Доступ закрыт

Доступ предоставлен
Доступ закрыт

Только для подписчиков

Аннотация
Об авторах
Список литературы
Статистика

Аннотация

Amethod for determining anticomplementary activity of human immunoglobulin (Ig) preparations for i.v. administration by complement fixation test was validated for accuracy, precision (repeatability, intralaboratory precision), limit of quantitation (LOQ), linearity, and analytical domain. The method could be used for quality assessment using the “anticomplementary activity” as part of the pharmaceutical quality examination of human Ig preparations.